Find your path to Charles
317 people in our graph can introduce you to Charles.
Sign up to see every warm intro you have to Charles
- Paths you didn't know you had: your email and LinkedIn already hold routes to Charles. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Dr. Charles J. Ryan is a genitourinary oncologist focused on prostate cancer biology and treatment who leads NXP's work on advancing cancer therapies and technologies. He earned a BA in Philosophy from Marquette University and an MD from the University of Wisconsin Medical School, trained at Memorial Sloan Kettering Cancer Center, and previously served as a professor and Associate Director at UCSF's Helen Diller Family Comprehensive Cancer Center. He led clinical trials contributing to the development and FDA approval of Abiraterone, served as CEO of the Prostate Cancer Foundation from 2021 to 2024, and is Medical Director of the PCCTC and a faculty member at Memorial Sloan Kettering Cancer Center.
Invests in
BiotechHealthtechMedical Devices
Experience
- ZERO Prostate CancerBoard Membercurrent2026 — present
- Memorial Sloan Kettering Cancer CenterMember and Attendingcurrent2024 — presentNew York, New York, United States
- The Prostate Cancer Clinical Trials Consortium (PCCTC)Medical Directorcurrent2024 — present
- Prostate Cancer FoundationChief Executive Officer2021 — 2024
- University of MinnesotaDirector, Division of Hematology, Oncology and Bone Marrow Transplantation, Assoc. Dir. Masonic CCC2018 — 2021
- University of MinnesotaBJ Kennedy Chair in Clinical Oncology2018 — 2021
- University of California, San FranciscoThomas Perkins Distinguished Professor for Clinical Cancer Research2014 — 2018
- University of California, San FranciscoProfessor of Medicine2003 — 2018
- GU Medical Oncology at UCSFLeader2008 — 2018
- Memorial Sloan Kettering Cancer CenterFellow2000 — 2003New York, United States
Skills & more
Languages Spanish
- VC Due Diligence (Online) — Columbia Business School
- Strategic Perspectives in Nonprofit Management — Harvard Business School Executive Education
- Venture Capital Private Equity — Columbia Business School
From Charles's professional profile.
Colleagues at Nextwave [X] Partners
Frequently asked questions
- Who is Charles J. Ryan?
- Dr. Charles J. Ryan is a genitourinary oncologist focused on prostate cancer biology and treatment who leads NXP's work on advancing cancer therapies and technologies. He earned a BA in Philosophy from Marquette University and an MD from the University of Wisconsin Medical School, trained at Memorial Sloan Kettering Cancer Center, and previously served as a professor and Associate Director at UCSF's Helen Diller Family Comprehensive Cancer Center. He led clinical trials contributing to the development and FDA approval of Abiraterone, served as CEO of the Prostate Cancer Foundation from 2021 to 2024, and is Medical Director of the PCCTC and a faculty member at Memorial Sloan Kettering Cancer Center.
- Where does Charles J. Ryan work?
- Charles J. Ryan is MD at Nextwave [X] Partners.
- What does Charles J. Ryan invest in?
- Charles J. Ryan invests in Biotech, Healthtech, Medical Devices.
- Where did Charles J. Ryan go to school?
- Charles J. Ryan studied at University of Wisconsin-Madison (Doctor of Medicine (MD)); Marquette University (Philosophy).
Same school
Also attended University of Wisconsin-Madison670
+ 664 more
Also attended Marquette University126
+ 120 more
Shared employers
Also worked at Memorial Sloan Kettering Cancer Center79
+ 73 more
Also worked at Prostate Cancer Foundation3
Also worked at University of Minnesota89
+ 83 more
Also worked at University of California, San Francisco193
+ 187 more












































